NLRP3 and chronic myelogenous leukemia, BCR-ABL1 positive: NLRP3 inflammasome pathway failure has been linked to a variety of inflammation-induced disorders, and genetic variation in the NLRP3 inflammasome pathway gene has been linked to the development of malignant tumors such as chronic myeloid leukemia and melanoma [119].